4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with Intestinal Polyps in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mutoh, M; Niho, N; Sugimura, T; Takahashi, M; Tsutsumi, K; Wakabayashi, K | 1 |
| Mutoh, M; Niho, N; Wakabayashi, K | 1 |
1 review(s) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Intestinal Polyps
| Article | Year |
|---|---|
Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice.
Topics: Age Factors; Animals; Benzamides; Bezafibrate; Cyclooxygenase 2; Genes, APC; Humans; Hyperlipidemias; Intestinal Polyps; Lipoprotein Lipase; Membrane Proteins; Mice; Organophosphorus Compounds; Pioglitazone; PPAR alpha; PPAR gamma; Thiazolidinediones; Triglycerides | 2006 |
1 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Intestinal Polyps
| Article | Year |
|---|---|
Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice.
Topics: Animals; Anticarcinogenic Agents; Benzamides; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cyclooxygenase 2; Female; Hyperlipidemias; Hypolipidemic Agents; Intestinal Polyps; Lipoprotein Lipase; Mice; Mice, Inbred C57BL; Organophosphorus Compounds; Prostaglandin-Endoperoxide Synthases; RNA, Messenger | 2005 |